Evidence map›Paper›PMID 26258904›Full record

ArticlePloS one2015

Artificial Loading of ASC Specks with Cytosolic Antigens.

Ali Can Sahillioğlu, Nesrin Özören

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Assembly and regulation of ASC specks.Cellular and molecular life sciences : CMLS · 2017
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ali Can SahillioğluApoptosis and Cancer Immunology Laboratory (AKiL), Department of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey.
Nesrin ÖzörenApoptosis and Cancer Immunology Laboratory (AKiL), Department of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey; Life Sciences and Technologies Research Center, Bogazici University, Istanbul, Turkey.
Boğaziçi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammasome complexes form upon interaction of Nod Like Receptor (NLR) proteins with pathogen associated molecular patterns (PAPMS) inside the cytosol. Stimulation of a subset of inflammasome receptors including NLRP3, NLRC4 and AIM2 triggers formation of the micrometer-sized spherical supramolecular complex called the ASC speck. The ASC speck is thought to be the platform of inflammasome activity, but the reason why a supramolecular complex is preferred against oligomeric platforms remains elusive. We observed that a set of cytosolic proteins, including the model antigen ovalbumin, tend to co-aggregate on the ASC speck. We suggest that co-aggregation of antigenic proteins on the ASC speck during intracellular infection might be instrumental in antigen presentation.

Indexed as

Antigen PresentationAntigensCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCarrier ProteinsCaspase 1Cell DifferentiationCytoskeletonCytosolDNA-Binding ProteinsGreen Fluorescent ProteinsHEK293 CellsHumansInflammasomesInflammationMacrophagesAIM2 protein, humanAntigensCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCarrier ProteinsCaspase 1DNA-Binding ProteinsGreen Fluorescent ProteinsInflammasomesNLRC4 protein, humanNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanOvalbuminProteasome Endopeptidase ComplexTetradecanoylphorbol AcetateUbiquitin

Identifiers

PMID26258904
PMCPMC4530869
OpenAlexW1913864807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.